JP2003506429A - (r)および(s)−カルニチンのニトリルオキシ誘導体 - Google Patents

(r)および(s)−カルニチンのニトリルオキシ誘導体

Info

Publication number
JP2003506429A
JP2003506429A JP2001515286A JP2001515286A JP2003506429A JP 2003506429 A JP2003506429 A JP 2003506429A JP 2001515286 A JP2001515286 A JP 2001515286A JP 2001515286 A JP2001515286 A JP 2001515286A JP 2003506429 A JP2003506429 A JP 2003506429A
Authority
JP
Japan
Prior art keywords
compound
formula
carnitine
acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001515286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003506429A5 (cg-RX-API-DMAC10.html
Inventor
オレステ・ピッコロ
ロベルト・カスタニャーニ
パオロ・デ・ウィット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2003506429A publication Critical patent/JP2003506429A/ja
Publication of JP2003506429A5 publication Critical patent/JP2003506429A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001515286A 1999-08-05 2000-07-31 (r)および(s)−カルニチンのニトリルオキシ誘導体 Pending JP2003506429A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT99A000508 1999-08-05
IT1999RM000508A IT1306184B1 (it) 1999-08-05 1999-08-05 Nitrilossi derivati della (r) e (s)-carnitina.
PCT/IT2000/000325 WO2001010819A1 (en) 1999-08-05 2000-07-31 Nitroxy derivatives of (r) and (s)-carnitine

Publications (2)

Publication Number Publication Date
JP2003506429A true JP2003506429A (ja) 2003-02-18
JP2003506429A5 JP2003506429A5 (cg-RX-API-DMAC10.html) 2011-04-07

Family

ID=11406927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001515286A Pending JP2003506429A (ja) 1999-08-05 2000-07-31 (r)および(s)−カルニチンのニトリルオキシ誘導体

Country Status (16)

Country Link
US (2) US6395923B2 (cg-RX-API-DMAC10.html)
EP (1) EP1224161B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003506429A (cg-RX-API-DMAC10.html)
KR (1) KR100772205B1 (cg-RX-API-DMAC10.html)
AT (1) ATE276231T1 (cg-RX-API-DMAC10.html)
AU (1) AU6470400A (cg-RX-API-DMAC10.html)
CA (1) CA2379047A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20025A3 (cg-RX-API-DMAC10.html)
DE (1) DE60013876T2 (cg-RX-API-DMAC10.html)
DK (1) DK1224161T3 (cg-RX-API-DMAC10.html)
ES (1) ES2226896T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0203034A3 (cg-RX-API-DMAC10.html)
IT (1) IT1306184B1 (cg-RX-API-DMAC10.html)
PT (1) PT1224161E (cg-RX-API-DMAC10.html)
SK (1) SK287134B6 (cg-RX-API-DMAC10.html)
WO (1) WO2001010819A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010456A1 (it) 2001-07-26 2003-01-27 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di (r)- o (s)- amminocarnitina sale interno, dei suoi sali e dei suoi derivati.
US8466187B2 (en) * 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
EP3595584B1 (en) 2017-03-17 2026-07-22 AMO Groningen B.V. Diffractive intraocular lenses for extended range of vision
WO2019193539A1 (en) 2018-04-06 2019-10-10 Optimedica Corporation Methods and systems for changing a refractive property of an implantable intraocular lens
WO2020092243A1 (en) * 2018-10-29 2020-05-07 Lonza Inc. Method and composition for increasing the bioavailability of carnitine
US10703707B2 (en) 2018-11-07 2020-07-07 Industrial Technology Research Institute Method for preparing nitrate ester
CN115380239A (zh) 2019-12-30 2022-11-22 阿莫格罗宁根私营有限公司 用于视力治疗的具有不规则宽度的衍射轮廓的镜片
JP2024541338A (ja) 2020-11-12 2024-11-08 サーモライフ インターナショナル, エルエルシー 血中酸素飽和度を増大させる方法
EP4291206A4 (en) 2021-02-11 2025-01-08 Thermolife International, LLC A method of administering nitric oxide gas

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06199751A (ja) * 1992-12-21 1994-07-19 Sigma Tau Ind Farmaceut Riunite Spa 配置異性体副産物からのl−(−)−カルニチンの製造方法
JPH06306028A (ja) * 1993-04-08 1994-11-01 Sigma Tau Ind Farmaceut Riunite Spa 反対立体配置の廃棄物からのl−(−)−カルニチンの改良製造法
WO1998056759A2 (de) * 1997-06-11 1998-12-17 Isis Pharma Gmbh Neue pentaerythritderivate, deren herstellung und verwendung sowie intermediate zur synthese derselben

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US5214166A (en) * 1986-11-29 1993-05-25 The United States Of America As Represented By The Secretary Of The Navy Method of synthesizing nitrato alkyl oxetanes
CH679856A5 (cg-RX-API-DMAC10.html) * 1990-07-04 1992-04-30 Lonza Ag
IT1261489B (it) * 1993-07-29 1996-05-23 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r amminocarnitina e s amminocarnitina.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06199751A (ja) * 1992-12-21 1994-07-19 Sigma Tau Ind Farmaceut Riunite Spa 配置異性体副産物からのl−(−)−カルニチンの製造方法
JPH06306028A (ja) * 1993-04-08 1994-11-01 Sigma Tau Ind Farmaceut Riunite Spa 反対立体配置の廃棄物からのl−(−)−カルニチンの改良製造法
WO1998056759A2 (de) * 1997-06-11 1998-12-17 Isis Pharma Gmbh Neue pentaerythritderivate, deren herstellung und verwendung sowie intermediate zur synthese derselben

Also Published As

Publication number Publication date
KR20020025213A (ko) 2002-04-03
US20020119965A1 (en) 2002-08-29
ES2226896T3 (es) 2005-04-01
KR100772205B1 (ko) 2007-11-01
SK1752002A3 (en) 2002-06-04
ITRM990508A0 (it) 1999-08-05
ITRM990508A1 (it) 2001-02-05
ATE276231T1 (de) 2004-10-15
DK1224161T3 (da) 2005-01-24
HUP0203034A3 (en) 2003-11-28
DE60013876D1 (de) 2004-10-21
HUP0203034A2 (hu) 2003-02-28
US20010011074A1 (en) 2001-08-02
PL358333A1 (en) 2004-08-09
SK287134B6 (sk) 2010-01-07
IT1306184B1 (it) 2001-05-30
WO2001010819A1 (en) 2001-02-15
US6395923B2 (en) 2002-05-28
PT1224161E (pt) 2005-01-31
EP1224161B1 (en) 2004-09-15
US6548693B2 (en) 2003-04-15
DE60013876T2 (de) 2005-09-29
AU6470400A (en) 2001-03-05
CA2379047A1 (en) 2001-02-15
EP1224161A1 (en) 2002-07-24
CZ20025A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
JP3778516B2 (ja) 新規なアリールプロピオン酸誘導体、その製造方法及び鎮痛薬としてのその用途
JP3231042B2 (ja) 2−(2,6−ジ−ハロ−フェニルアミノ)フェニル酢酸の誘導体の硝酸エステルおよびその製造法
JPH07285860A (ja) L−dopaエステルの組成物
JPH06102623B2 (ja) 中枢神経興奮剤
US20240383830A1 (en) Novel cannabidiol derivative, method for preparing same, and composition for cognitive function improvement comprising same
JPH09511516A (ja) グルカミン誘導体を用いるエトドラックの分割法
KR100772205B1 (ko) (r) 및 (s)-카르니틴의 니트록시 유도체
IT8448503A1 (it) Estere della acetil carnitina, procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono
JP5006311B2 (ja) 置換テトラフルオロベンジルアニリン化合物、及びその薬学的に許容される塩の製造方法
CN1829683B (zh) 米屈肼盐及其制备方法以及基于米屈肼盐的药物组合物
JPH08511008A (ja) 複素環式化学
JP2003506429A5 (cg-RX-API-DMAC10.html)
JP2002521469A (ja) R−(−)−カルニチンの調製法
JP2002504903A (ja) ペンタエリスリトール新規誘導体、その製造及び使用、並びにその合成の為の中間体
JPH05105627A (ja) 腸機能性疾患の治療に用いられる新規な医薬組成物と、その調整方法と、治療用医薬の調製方法
JP2656720B2 (ja) 光学活性アミノクマラン誘導体
JP2008537935A (ja) トルペリゾンの付加塩、その製造方法およびその使用
WO1995004058A1 (fr) Sel de codeine de l'acide 2-(3-benzoylphenyl)propionique, procede d'obtention et compositions pharmaceutiques le contenant
CN120098058A (zh) 三氮唑并环类化合物及其制法、药物组合物和应用
JP3186167B2 (ja) アセチルサリチロイル−l−カルニチンおよびその製造方法
JPH09176157A (ja) 光学活性アミノクマラン誘導体
FR2527210A1 (fr) Enantiomeres d'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de) (naphtyridine-1,5), leur procede de separation et leur application en therapeutique
JPH07507573A (ja) クラブラン酸のジアミン塩
HK1030608A (en) Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070731

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100803

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101102

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101202

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101209

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110111

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120821